Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 10.1145 | 98 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 9.6641 | 97 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 9.87496 | 98 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.1359 | 98 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 9.69265 | 97 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 9.84758 | 98 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.2311 | 98 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 10.0336 | 98 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 9.93664 | 98 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 9.93883 | 98 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 9.6133 | 98 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 10.1835 | 98 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 9.95154 | 98 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 9.89629 | 98 |